Archive - February 2018
AllTrials puts FDA under pressure with Trials Tracker
GW’s cannabinoid fails in focal seizures trial
Maryland ponders ways to stabilize health insurance markets
NICE rejects Eisai’s Halaven in earlier setting for metastatic breast cancer
Arix ties with Ipsen
NHS books £1.2bn deficit and 100,000 empty posts
Beyond ‘Obamacare’: New liberal plan on healthcare overhaul
CDC U-turns previous decision on AZ’s flu vaccine